These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8741935)

  • 1. Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat.
    Tanda G; Bassareo V; Di Chiara G
    Psychopharmacology (Berl); 1996 Jan; 123(2):127-30. PubMed ID: 8741935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex.
    Devoto P; Flore G; Saba P; Bini V; Gessa GL
    Addict Biol; 2014 Jul; 19(4):612-22. PubMed ID: 23289939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis.
    Kawahara H; Kawahara Y; Westerink BH
    Eur J Pharmacol; 2001 Apr; 418(3):177-86. PubMed ID: 11343687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of caffeine on dopamine and acetylcholine transmission in brain areas of drug-naive and caffeine-pretreated rats.
    Acquas E; Tanda G; Di Chiara G
    Neuropsychopharmacology; 2002 Aug; 27(2):182-93. PubMed ID: 12093592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine.
    Valentini V; Frau R; Di Chiara G
    J Neurochem; 2004 Feb; 88(4):917-27. PubMed ID: 14756813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat.
    Bassareo V; Tanda G; Petromilli P; Giua C; Di Chiara G
    Psychopharmacology (Berl); 1996 Apr; 124(4):293-9. PubMed ID: 8739543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors.
    Di Matteo V; Di Mascio M; Di Giovanni G; Esposito E
    Psychopharmacology (Berl); 2000 May; 150(1):45-51. PubMed ID: 10867975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
    Li Z; Ichikawa J; Dai J; Meltzer HY
    Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
    Nomikos GG; Iurlo M; Andersson JL; Kimura K; Svensson TH
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell.
    King D; Zigmond MJ; Finlay JM
    Neuroscience; 1997 Mar; 77(1):141-53. PubMed ID: 9044382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
    Ichikawa J; Meltzer HY
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
    Ichikawa J; Kuroki T; Dai J; Meltzer HY
    Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of loxapine with ziprasidone and thioridazine on the release of dopamine and acetylcholine in the prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Meltzer HY
    Psychopharmacology (Berl); 2003 May; 167(3):315-23. PubMed ID: 12664192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.
    Murata M; Katagiri N; Ishida K; Abe K; Ishikawa M; Utsunomiya I; Hoshi K; Miyamoto K; Taguchi K
    Brain Res; 2009 May; 1269():40-6. PubMed ID: 19285043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors.
    Feenstra MG; Botterblom MH; van Uum JF
    J Neurochem; 1998 Mar; 70(3):1104-13. PubMed ID: 9489731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine.
    Darracq L; Blanc G; Glowinski J; Tassin JP
    J Neurosci; 1998 Apr; 18(7):2729-39. PubMed ID: 9502830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.